In Focus

Asian medical device markets face cost shocks amidst Iran conflict

The Strait of Hormuz is the chokepoint of the market.
2 days ago

Neurological disorders and aging boost brain-computer interface market

Government and private investment accelerates innovation.

Cardiac monitoring devices market to hit $37.88b by 2031

Asia-Pacific is expected to post the highest growth rate.

Rising demand for advanced surgical devices to push market to $27.4b by 2032

Robotic-assisted surgery drives precision in complex procedures.

Affordability wall drives institutional exit from Thai healthcare stocks

Patient shift to public hospitals capped Thailand’s private healthcare growth at 3%.

HSA clears cancer-detecting AI for routine hospital use

Intelligent Scopes Corp secures regulatory green light for its new bladder cancer software.

Healthcare asset tracking to hit $22.4b as hospitals go digital

Market to adopt AI, 5G, and blockchain for healthcare efficiency.

US tariffs trigger 123% Singapore pharma output surge

Combined US and China markets account for 38% of all Singapore pharma exports.

Human microbiome drugs market to be valued at $2.13b by 2031

By end users, the hospitals & clinics segment held the largest market share in 2024.

Radjak launches rapid cardiac, stroke unit for urban emergencies

It may roll out the model across its urban hospitals as demand grows. 

Respiratory CGT development remains limited as funding drops

However, R&D efforts on automation and AI are advancing manufacturing.

Breast cancer drugs market to be valued at $57.1b by 2031

By end user, hospitals accounted for about 46% of the total market value.

What lies ahead for the cell and gene therapy market?

Major investors have committed over $3.5b across cumulative deals.